Start: May 06, 2022
End: May 10, 2022

Highlights of the TomoTherapy® and CyberKnife-related abstract submissions to ESTRO 2022 can be found below.

CyberKnife®

Breast
  • OC-0932: Preoperative Radiation Therapy in Early Breast Cancer: Phase II ROCK Trial (NCT03520894). Luca Visani1, Icro Meattini1, Giulio Francolini1, Vanessa Di Cataldo1, Carlotta Becherini1, Jacopo Nori2, Marco Bernini3, Lorenzo Orzalesi3, Luis Sanchez3, Erika Scoccimarro1, Sara Lucidi1, Chiara Bellini1, Isacco Desideri1, Vieri Scotti1, Raffaela Doro4, Laura Masi4, Mauro Loi1, Simonetta Bianchi5, Monica Mangoni1, Lorenzo Livi1. 1University of Florence, Department of Experimental and Clinical Biomedical Sciences, Florence, Italy; 2Azienda Ospedaliero-Universitaria Careggi, Diagnostic Senology Unit, Florence, Italy; 3Azienda Ospedaliero-Universitaria Careggi, Breast Surgery Unit, Florence, Italy; 4Istituto Fiorentino di Cura e Assistenza, Department of Medical Physics, Florence, Italy; 5Azienda Ospedaliero-Universitaria Careggi, Pathology Unit, Florence, Italy
  • PO-1177: Acute Toxicity of Hypofractionated Locoregional Radiotherapy in Advanced Breast Cancer. Roberta Tummineri1, Andrei Fodor1, Flavia Zerbetto1, Marcella Pasetti1, Chiara Lucrezia Deantoni1, Ariadna Sanchez Galvan2, Roberta Castriconi3, Paola Mangili3, Antonella Del Vecchio3, Nadia Gisella Di Muzio4. 1IRCCS San Raffaele Scientific Institute, Radiation Oncology, Milano, Italy; 2Milano-Bicocca University, Radiation Oncology, Milano, Italy; 3IRCCS San Raffaele Scientific Institute, Medical Physics, Milano, Italy; 4IRCCS San Raffaele Scientific Institute - Università Vita-Salute, Radiation Oncology, Milano, Italy
  • PO-1226: Stereotactic APBI for Early-Stage Breast Cancer: Acute Toxicity Outcomes of a Prospective Trial. Jonathan Cantalino1, Brian Collins1, Malika Danner1, Sonali Rudra1, Simeng Suy1, Sean Collins1, Monica Pernia Marin2, Michael Good3, Deborah Markiewicz3, Rachelle Lanciano3, Olusola Obayomi-Davies4. 1Medstar Georgetown University Hospital, Department of Radiation Medicine, Washington, DC, USA; 2The George Washington University Hospital, Geriatric and Palliative Care Division, Washington, DC, USA; 3Philadelphia Cyberknife, Crozer Keystone Health Care Center, Department of Radiation Oncology, Havertown, PA, USA; 4Wellstar Medical Group, Department of Radiation Oncology, Marietta, GA, USA
  • PO-1237: Implementation of SAPBI using CyberKnife: Dosimetry Report and Early Experiences of a Phase II Trial. Norbert Mészáros1, Viktor Smanykó1, Tibor Major1, Gábor Stelczer2, Levente Jánváry1, Zoltán Takácsi-Nagy1, Csaba Polgár1. 1National Institute of Oncology, Center of Radiotherapy, Budapest, Hungary; 2National Institute of Oncology, Center of Radiotherapy, Budapest, Hungary
Intracranial
  • PD-0248: Treatment Outcomes Following CyberKnife Radiosurgery for Refractory Trigeminal Neuralgia. Marina Amorim1, Catarina Silva1, Maria Adelina Costa2, Graça Fonseca2, Cármen Calçada2, João Conde2, Osvaldo Carvalhosa1, Sofia Ramos1, Joana Vale2, Ana Cavaco2, Pedro Vieira2, Paula Genésio2, Paulo Costa2,1. 1Hospital de Braga, Radiation Oncology, Braga, Portugal; 2Instituto CUF - Júlio Teixeira S.A., Radiation Oncology, Porto, Portugal
  • PO-1125: Long-term efficacy and toxicity following CyberKnife radiation for Vestibular Schwannoma. Lucy Solway1, Hickman Mitchell2, Sara Meade2, Helen Benghiat2, Hannah Augustus2, Ruth Stange2, Timothy Jackson2, Geoff Heyes2, Peter Monksfield3, Andrew Kay4, Richard Irving3, Swarupsinh Chavda5, Andrew Hartley2, Paul Sanghera2. 1Univerity Hospital Birmingham, Oncology, Birmingham, United Kingdom; 2University Hospital Birmingham, Oncology, Birmingham, United Kingdom; 3University Hospital Birmingham, ENT, Birmingham, United Kingdom; 4University Hospital Birmingham, Neurosurgery, Birmingham, United Kingdom; 5University Hospital Birmingham, Radiology, Birmingham, United Kingdom
  • PO-1128: Radiosurgery with CyberKnife for Arteriovenous Malformations: Technical and Dosimetrical Analysis. Esmeralda Scipilliti1, Valentina Borzillo1, Rossella Di Franco1, Federica Savino2, Giuseppe Leone3, Mario Muto3, Paolo Muto4. 1Istituto Nazionale Tumori IRCSS Fondazione G. Pascale, Radiation Oncology Unit, Napoli, Italy; 2LB Servizi per le aziende SRL, Medical physics, Roma, Italy; 3A.O.R.N. Cardarelli, Department of Neuroradiology, Napoli, Italy; 4Istituto Nazionale Tumori Fondazione G. Pascale, Radiation Oncology Unit, Napoli, Italy
  • PO-1138: Stereotactic Radiosurgery in the Management of Vestibular Schwannoma: a Single-institution Experience. Catarina Silva1, Marina Amorim1, M. Adelina Costa2, Graça Fonseca2, Carlos Fardilha2, João Gagean2, Sara Simões1, Fernanda Ponte2, Guilherme Campos2, Carla Seixas2, Fátima Rodrigues2, Paulo Costa1,2. 1Hospital de Braga, Radiation Oncology, Braga, Portugal; 2CUF Porto Instituto - Júlia Teixeira S.A., Radiation Oncology, Porto, Portugal
  • PO-1158: Re-irradiation with Stereotactic Radiotherapy for Recurrent High Grade Glial Tumors. Ela Delikgoz Soykut1, Eylem Odabasi1, Nilgun Sahin1. 1Samsun Training and Research Hospital, Radiation Oncology, Samsun, Turkey
Gastrointestinal
Genitourinary
  • PD-0411: Predictive factors of late GU toxicity after CyberKnife re-irradiation for locally recurrent PCa. Giulio Francolini1, Cecilia Cerbai2, Mauro Loi1, Vanessa Di Cataldo3, Beatrice Detti4, Gabriele Simontacchi1, Lucia Pia Ciccone2, Laura Masi5, Raffaella Doro5, Andrea Allegra2, Viola Salvestrini2, Chiara Mattioli2, Giulio Frosini6, Luca Burchini2, Michele Aquilano2, Giulia Stocchi2, Isacco Desideri2, Lorenzo Livi7. 1Azienda Ospedaliero Universitaria Careggi, Radiation Oncology Unit Oncology Department, Florence, Italy; 2University of Florence, Department of Experimental and Clinical Biomedical Sciences "M. Serio", Florence, Italy; 3Istituto Fiorentino di Cura e Assistenza (IFCA), Radiation Oncology CyberKnife Center, Florence, Italy; 4Azienda Ospedaliero Universitaria Careggi, Radiation Oncology Unit, Oncology Department, Florence, Italy; 5Istituto Fiorentino di Cura e Assistenza (IFCA), Department of Medical Physics, Radiation Oncology CyberKnife Center, Florence, Italy; 6 University of Florence, Department of Experimental and Clinical Biomedical Sciences "M. Serio", Florence, Italy; 7University of Florence - Department of Experimental and Clinical Biomedical Sciences "M. Serio", Azienda Ospedaliero Universitaria Careggi - Radiation Oncology Unit Oncology Department, Florence, Italy
  • PO-1365: SBRT for locally recurrent prostate cancer after prostatectomy and post-operative radiotherapy. Wojciech Majewski1, Bartlomiej Goc1, Donata Graupner1, Marcin Miszczyk1. 1Maria Sklodowska-Curie National Research Institute of Oncology, Radiotherapy Department, Gliwice, Poland
  • PO-1370: Metastasis-Directed Therapy with CyberKnife for Oligometastatic Prostate Cancer. Sebastian Exner1, Fabian Fehlauer1, Saul Esteve Grau1. 1Strahlenzentrum Hamburg, Radiotherapy, Hamburg, Germany
  • PO-1372: Robotic Stereotactic Body Radiotherapy for Prostate Cancer: an Initial Mono-institutional Experience. Ariadna Sanchez Galvan1, Andrei Fodor1, Claudio Fiorino2, Paola Mangilli2, Chiara Lucrezia Deantoni1, Cesare Cozzarini1, Roberta Tummineri1, Simone Baroni1, Stefano Lorenzo Villa1, Giuseppina Mandurino1, Pietro Pacifico1, Stefano Arcangeli3, Nadia Gisella Di Muzio4,5. 1IRCCS San Raffaele Scientific Institute, Radiotherapy, Milan, Italy; 2IRCCS San Raffaele Scientific Institute, Medical Physics, Milan, Italy; 3University of Milano-Bicocca, Radiotherapy, Monza, Italy; 4 IRCCS San Raffaele Scientific Institute, Radiotherapy, Milan, Italy; 5Vita-Salute San Raffaele University, Radiotherapy, Milan, Italy
  • PO-1392: SBRT Monotherapy for Low and Intermediate Risk Prostate Cancer First Chilean Experience. María Fernanda Sánchez1, Felipe Maza2, Federico Bakal1, Piero Bettoli1. 1Fundación Arturo López Pérez, Department of Radiation Oncology, Santiago, Chile; 2Fundación Arturo López Pérez, Unidad de Evaluación de Tecnologías Sanitarias, Santiago, Chile
  • PO-1469: CT-Guided Fiducial Placement for Robotic Stereotactic Body Radiotherapy: Efficacy and Safety. Mauro Loi1, Ivano Bonucci2, Laura Masi2, Raffaella Doro3, Giulio Francolini1, Vanessa Di Cataldo3, Pierluigi Bonomo1, Luca Visani3, Marco Tempobono3, Niccolo Bellosi3, Silvia Pazzaglini3, Marco Cassinelli3, Gabriele Simontacchi1, Daniela Greto1, Isacco Desideri4, Sara Lucidi4, Michele Aquilano4, Lorenzo Livi4. Azienda Ospedaliero-Universitaria Careggi, Radiation Oncology, Florence, Italy; 2Istituto Fiorentino di Cura e Assistenza (IFCA), Radiation Oncology, Florence, Italy; 3Istituto Fiorentino di Cura e Assistenza (IFCA), Radiation Oncology, Florence, Italy; 4University of Florence, Radiation Oncology, Florence, Italy
Lung
  • PO-1246: Lung SBRT after Pneumonectomy. Angela Botticella1, Antonin Levy1, Olaf Mercier2, Guillaume Auzac1, Aicha Traore-Diallo3, Maxime Frelaut4, Pauline Pradere2, Caroline Caramella5, Ines Kasraoui6, Benjamin Besse4, David Planchard4, Cécile Le Pechoux1. 1Gustave Roussy, Radiation Oncology, Villejuif, France; 2Marie-Lannelongue Hospital, Thoracic and Vascular Surgery and Heart-Lung Transplantation Department, Plessis Robinson, France; 3Gustave Roussy, Radiation Oncology, Villejuif, France; 4Gustave Roussy, Oncology Department, Villejuif, France; 5Marie-Lannelongue Hospital, Radiology Department, Plessis Robinson, France; 6Gustave Roussy, Radiology Department, Villejuif, France
Metastases
  • PO-1228: Radiosurgery in Her2-breast Cancer Brain Metastasis: Local Control and Overall Survival in 32 Women. Samantha Dicuonzo1, Francesca Colombo2, Luca Bergamaschi2, Gaia Piperno1, Annamaria Ferrari1, Maria Cristina Leonardi1, Mattia Zaffaroni1, Maria Alessia Zerella1, Damaris Patricia Rojas1, Marianna Alessandra Gerardi1, Anna Morra1, Elena Rondi3, Sabrina Vigorito3, Federica Cattani3, Roberto Orecchia4, Barbara Alicja Jereczek-Fossa1, Samuele Frassoni5, Vincenzo Bagnardi5. 1European Institute of Oncology IRCCS, Department of Radiotherapy, Milan, Italy; 2University of Milan/European Institute of Oncology IRCCS, Department of Oncology and Hemato-Oncology/Department of Radiotherapy, Milan, Italy; 3European Institute of Oncology IRCCS, Unit of Medical Physic, Milan, Italy; 4European Institute of Oncology IRCCS, Scientific Directorate, Milan, Italy; 5University of Milan-Bicocca, Department of Statistics and Quantitative Methods, Milan, Italy
Oligometastases
  • PO-1261: Is SBRT an effective treatment in metastatic lung cancer with oligoprogressive disease? Michele Aquilano1, Mauro Loi2, Lorenzo Livi3, Joost Nuyttens4. 1University of Florence, Department of Biomedical, Experimental and Clinical Sciences "Mario Serio" University of Florence, Florence, Italy; 2Azienda Ospedaliero-Universitaria Careggi, Department of Radiation Oncology, Florence, Italy; 3University of Florence, Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", Florence, Italy; 4Erasmus MC Cancer Institute, Department of Radiation Oncology, Rotterdam, The Netherlands
Physics

TomoTherapy® / Radixact®

Intracranial
  • MO-0725: Hippocampal sparing WBRT: Trade-off Between Tumor Control and Quality of Life. Giulia Corrao1, Luca Bergamaschi1, Vanessa Eleonora Pierini1, Annamaria Ferrari2, Gaia Piperno2, Giulia Marvaso1, Francesca Emiro3, Matteo Pepa4, Sara Gandini5, Federica Cattani3, Roberto Orecchia6, Barbara Alicja Jereczek-Fossa2. 1IEO, European Institute of Oncology IRCCS; University of Milan, Division of Radiation Oncology; Department of Oncology and Hematoncology, Milan, Italy; 2IEO, European Institute of Oncology IRCCS, Division of Radiation Oncology, Milan, Italy; 3IEO, European Institute of Oncology IRCCS, Unit of Medical Physics, Milan, Italy; 4IEO, European Institute of Oncology IRCCS, Division of Radiation Oncology; Department of Oncology and Hematoncology, Milan, Italy; 5IEO, European Institute of Oncology IRCCS, Department of Experimental Oncology, Milan, Italy; 6IEO, European Institute of Oncology, IRCCS, Scientific Directorate, Milan, Italy
Gastrointestinal
  • MO-0220: Dose-volume constraints for gastric and duodenal toxicity in pancreas moderately hypofractionated RT. Sara Broggi1, Paolo Passoni2, Paolo Tiberio1, Alessandro Cicchetti3, Barbara Longobardi4, Najla Slim2, Michele Reni5, Antonella Del Vecchio1, Nadia Gisella Di Muzio2, Claudio Fiorino1. 1San Raffaele Scientific Institute, Medical Physics, Milano, Italy; 2San Raffaele Scientific Institute, Radiotherapy, Milano, Italy; 3San Raffaele Scientific Institute, Medical Physics, Milano, Italy; 4San Raffaele Scientific Institute, Medical Physics, Milano, Italy; 5San Raffaele Scientific Institute, Oncology, Milano, Italy
  • PO-1324: Accelerated Hypofractionation with SIB-IMRT in Anal Cancer: Assessment of Efficacy and Toxicity. Sara Lucidi1, Niccolò Bertini1, Mauro Loi2, Pierluigi Bonomo2, Giulio Francolini2, Daniela Greto2, Gabriele Simontacchi2, Alessandra Galardi2, Livia Marrazzo3, Andrea Allegra4, Barbara Guerrieri4, Erika Scoccimarro4, Matteo Mariotti4, Maria Grazia Carnevale4, Giulia Stocchi4, Lucia Pia Ciccone4, Anna Peruzzi4, Victoria Lorenzetti4, Cinzia Talamonti3, Stefania Pallotta3, Monica Mangoni4, Lorenzo Livi4. 1University of Florence, Department of Biomedical, Experimental, and Clinical Sciences M. Serio, Florence, Italy; 2Azienda Ospedaliero-Universitaria Careggi, Radiation Oncology, Florence, Italy; 3Azienda Ospedaliero-Universitaria Careggi, Medical Physics Unit, Florence, Italy; 4University of Florence, Department of Experimental and Clinical Biomedical Sciences '' M. Serio'', Florence, Italy
GYN
Head & Neck

PD-0808: Actual dose evaluation for establishing a quick assessment for adaptive radiotherapy in NPC cases. MEI SUET WONG1, Wing Ki Fung1, Chi Leung Chiang2, George Chiu1. 1Hong Kong Sanatorium & Hospital, Department of Radiotherapy, Hong Kong, Hong Kong (SAR) China; 2The University of Hong Kong, Department of Clinical Oncology, Hong Kong, Hong Kong (SAR) China

Long-fields
  • OC-0589: Successful pregnancies after helical Tomotherapy craniospinal irradiation for adult medulloblastoma. Elisa Coassin1, Loredana Barresi2, Cristina Cappelletto2, Alicia Tosoni3, Paola Chiovati2, Annalisa Drigo2, Alba Brandes3, Maurizio Mascarin1. 1Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, AYA Oncology and Pediatric Radiotherapy Unit - High Technology Department, Aviano, Italy; 2Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Medical Physics Division - High Technology Department, Aviano, Italy; 3IRCSS Istituto di Scienze Neurologiche di Bologna, Nervous System Medical Oncology Department, Bologna, Italy
  • PD-0326: UK National Survey of Craniospinal Irradiation: Immobilisation and treatment techniques. Sophie Alexander1, Kim Robinson2, Lindsay Sellman1, Sarah Mowat1, Henry Mandeville1,3. 1The Royal Marsden NHS Foundation Trust, Radiotherapy, Sutton, United Kingdom; 2The Royal Marsden NHS Foundation Trust, Radiotherapy, Sutton, United Kingdom; 3The Institute of Cancer Research, Division of Radiotherapy & Imaging, Sutton, United Kingdom
  • PO-1171: Ten-year Follow-up of Tandem Autologous Transplantation with Total Marrow Irradiation for Myeloma. Colton Ladbury1, Amalia Rincon2, Joo Song3, Saro Armenian2, An Liu1, Ricardo Spielberger2, Leslie Popplewell2, Firoozeh Sahebi2, Pablo Parker2, Stephen Forman2, David Snyder2, Andy Dagis4, Paul Frankel4, Dongyun Yang4, Jeffrey Wong1, George Somlo2. 1City of Hope National Medical Center, Radiation Oncology, Duarte, USA; 2City of Hope National Medical Center, Hematology and Hematopoietic Cell Transplantation, Duarte, USA; 3City of Hope National Medical Center, Department of Pathology, Duarte, USA; 4City of Hope National Medical Center, Biostatistics, Duarte, USA
Metastases
  • PO-1449: Single Fraction Lumbopelvic Bone Irradiation with Helical TomoTherapy for Metastatic Bone Disease. Beatriz Gil Haro1, Sofía Santana Jiménez1, Jesús Romero Fernández1, Rafael Molerón Mancebo2, Raquel Benlloch Rodríguez1, Marta López Valcárcel1, María Hernández Miguel1, Irma Zapata Paz1, Ruth Rodríguez Romero3, Lucía Paisán Palacio1, Alfonso Valcárcel Díaz1, Patricia Sarrión Rubio de la Torre1. 1Puerta de Hierro University Hospital, Radiation Oncology, Madrid, Spain; 2Aberdeen Royal Infirmary NHS Grampian, Radiation Oncology, Aberdeen, United Kingdom; 3Puerta de Hierro University Hospital, Radiophysics, Madrid, Spain
Physics
Radiation Therapist
Skin
  • PO-1434: Innovative Radiotherapy Technique for the Treatment of In-transit or Metastatic Lower Limb Melanoma. Joaquin Velasco Jiménez1, Joaquín Velasco Jiménez2, Marta López Valcárcel3, Patricia Sánchez Rubio4, María Hernández Miguel3, Alfonso Valcárcel Diaz3, Lucía Paisan Palacio3, Sofia Santana Jimenez3, Beatriz Gil Haro3, Olga Engel3, Carlos A. Regueiro Otero5, Jesús Romero Fernández5. 1PUERTA DE HIERRO MAJADAHONDA HOSPITAL, RADIATION ONCOLOGY, MAJADAHONDA, Spain; 2CEU San Pablo, Medicina, MADRID, Spain; 3Puerta de Hierro Majadahonda Hospital, Radiation Oncology, Majadahonda, Spain; 4Puerta de Hierro Majadahonda Hospital, Physics, Majadahonda, Spain; 5Puerta de Hierro Majadahonda Hospital, Radiation Oncology, Majadahonda, Spain

CyberKnife® & TomoTherapy® / Radixact®

GYN
  • PD-0085: SBRT in the Management of Oligometastatic Gynecological Cancer: a Mono-institutional Experience. Giuseppina Mandurino1, Andrei Fodor2, Stefano Lorenzo Villa1, Flavia Zerbetto3, Simone Baroni1, Ariadna Sanchez Galvan4, Roberta Tummineri1, Chiara Lucrezia Deantoni1, Paola Mangili4, Antonella Del Vecchio4, Stefano Arcangeli1, Nadia Gisella Di Muzio1,5. 1IRCCS San Raffaele Scientific Institute, Department of Radiation Oncology, Milan, Italy; 2 IRCCS San Raffaele Scientific Institute, Department of Radiation Oncology, Milan, Italy; 3IRCCS San Raffaele Scientific Institute, Department of Radiation Oncology, Milan, Italy; 4IRCCS San Raffaele Scientific Institute,, Department of Radiation Oncology, Milan, Italy; 5Vita-Salute S. Raffaele University, Department of Radiation Oncology, Milan, Italy
Oligometastases
  • PD-0914: SBRT versus ENRT in oligometastatic gynecologic tumors: techniques comparison. Stefano Lorenzo Villa1, Andrei Fodor1, Giuseppina Mandurino1, Flavia Zerbetto1, Chiara Lucrezia Deantoni1, Ariadna Sanchez Galvan2, Roberta Tummineri1, Simone Baroni1, Jessica Saddi1, Paola Mangili3, Roberta Castriconi3, Stefano Arcangeli4, Nadia Gisella Di Muzio1,5. 1IRCCS San Raffaele Scientific Institute, Radiotherapy, Milan, Italy; 2IRCCS San Raffaele Scientific Institute, Radiotherapy, Milano, Italy; 3IRCCS San Raffaele Scientific Institute, Medical Physics, Milan, Italy; 4University of "Milano-Bicocca", Radiotherapy, Milan, Italy; 5“Vita-Salute San Raffaele” University, Radiotherapy, Milan, Italy
  • PO-1315: CT radiomic predictors of local relapse after SBRT for lung oligometastases from colorectal cancer. Martina Mori1, Roberta Tummineri2, Simone Baroni2, Michela Olivieri1, Sara Broggi1, Chiara Lucrezia Deantoni2, Paola Mangili1, Andrei Fodor2, Antonella Del Vecchio1, Claudio Antonio Fiorino1, Nadia Gisella Di Muzio2. 1IRCCS San Raffaele Scientific Institute, Medical Physics, Milan, Italy; 2IRCCS San Raffaele Scientific Institute, Radiotherapy, Milan, Italy